Antibody responses to common viruses according to COVID-19 severity and postacute sequelae of COVID-19

Karachaliou, Marianna; Ranzani, Otavio; Espinosa, Ana; Iraola Guzmán, Susana; Castaño Vinyals, Gemma; Vidal, Marta; Jiménez, Alfons; Bañuls, Marc; Alonso Nogués, Eva; Aguilar, Ruth; García Aymerich, Judith; Cid Ibeas, Rafael de; Dobaño, Carlota; Moncunill, Gemma; Kogevinas, Manolis

doi:http://dx.doi.org/10.1002/jmv.29862

Antibody responses to common viruses according to COVID-19 severity and postacute sequelae of COVID-19

Llicència

Citació

Karachaliou M, Ranzani O, Espinosa A, Iraola-Guzmán S, Castaño-Vinyals G, Vidal M, et al. Antibody responses to common viruses according to COVID-19 severity and postacute sequelae of COVID-19. J Med Virol. 2024 Sep;96(9):e29862. DOI: 10.1002/jmv.29862

Resum

Limited research suggests that certain viruses reactivate in severe-acute-respiratory-syndrome-coronavirus 2 infection, contributing to the development of postacute sequelae of COVID-19 (PASC). We examined 1083 infected individuals from a population-based cohort, and assessed differences in plasma immunoglobulin (Ig)G and immunoglobulin A levels against Epstein-Barr virus (EBV), cytomegalovirus, varicella zoster virus (VZV), BK polyomavirus, KI polyomavirus, WU polyomavirus (WUPyV), respiratory syncytial virus, and Adv-36 according to the severity of previous COVID-19 and PASC history. Individuals who had experienced severe COVID-19 had higher antibody responses to latent viruses. Ever PASC, active persistent PASC, and PASC with neuropsychiatric symptoms were associated with higher immnoglobulin G to EBV early antigen-diffuse, VZV, and WUPyV even among individuals without previous severe COVID-19.